Kai Yan

3.1k total citations
50 papers, 1.3k citations indexed

About

Kai Yan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Kai Yan has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Immunology and 14 papers in Cancer Research. Recurrent topics in Kai Yan's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Immune cells in cancer (5 papers) and Ferroptosis and cancer prognosis (4 papers). Kai Yan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Immune cells in cancer (5 papers) and Ferroptosis and cancer prognosis (4 papers). Kai Yan collaborates with scholars based in China, United States and France. Kai Yan's co-authors include W. Fraser Symmans, Gabriel N. Hortobágyi, Lajos Pusztai, Wenzheng Shi, Yuanfang Zhu, Jie Tian, Cornelia Liedtke, Attila Tordai, Fabrice André and Catherine Richon and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Kai Yan

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Yan China 20 637 615 389 178 173 50 1.3k
Lin Guo China 21 731 1.1× 440 0.7× 332 0.9× 138 0.8× 180 1.0× 71 1.3k
Yajun Yi United States 22 969 1.5× 490 0.8× 389 1.0× 247 1.4× 320 1.8× 31 1.7k
Michał Jarząb Poland 25 841 1.3× 372 0.6× 399 1.0× 207 1.2× 267 1.5× 102 1.7k
M Zerilli Italy 18 725 1.1× 349 0.6× 406 1.0× 239 1.3× 111 0.6× 31 1.4k
Brian M. Nolen United States 21 547 0.9× 364 0.6× 577 1.5× 282 1.6× 138 0.8× 28 1.6k
Antje Lebrecht Germany 23 407 0.6× 305 0.5× 610 1.6× 215 1.2× 147 0.8× 58 1.4k
Mohamed E. Abazeed United States 20 565 0.9× 449 0.7× 355 0.9× 226 1.3× 474 2.7× 67 1.6k
Lian Xu China 17 475 0.7× 316 0.5× 449 1.2× 145 0.8× 314 1.8× 40 1.1k

Countries citing papers authored by Kai Yan

Since Specialization
Citations

This map shows the geographic impact of Kai Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Yan more than expected).

Fields of papers citing papers by Kai Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Yan. The network helps show where Kai Yan may publish in the future.

Co-authorship network of co-authors of Kai Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Yan. A scholar is included among the top collaborators of Kai Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Yan. Kai Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Yaoyao, Guangtao Fu, Xiaoxue Wang, et al.. (2025). Inhibition of Aberrant Activated Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis by Leishmania Peptide via the Regulation of Fatty Acid Synthesis Metabolism. Advanced Science. 12(19). e2409154–e2409154. 5 indexed citations
3.
Jing, Ming, Sheng‐Xiao Zhang, Yang Wang, et al.. (2024). Discovery of PANoptosis-related signatures correlates with immune cell infiltration in psoriasis. PLoS ONE. 19(10). e0310362–e0310362. 2 indexed citations
4.
Yan, Kai, Ding Zhang, Yanan Chen, et al.. (2023). Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma. Frontiers in Immunology. 14. 1116057–1116057. 3 indexed citations
5.
Han, Zhe, et al.. (2023). Development and external validation of MRI‐based RAS mutation status prediction model for liver metastases of colorectal cancer. Journal of Surgical Oncology. 129(3). 556–567. 2 indexed citations
6.
Hao, Xiang, et al.. (2023). Quantum work extraction of an accelerated Unruh-DeWitt battery in relativistic motion. Physical review. A. 107(1). 6 indexed citations
7.
Yang, Qiong, Kai Yan, Rongrong Huang, et al.. (2022). Multi-Omics Profiling Identifies Pathways Associated With CD8+ T-Cell Activation in Severe Aplastic Anemia. Frontiers in Genetics. 12. 790990–790990. 15 indexed citations
8.
Chen, Zhen, Kai Yan, Liang Li, et al.. (2022). Immune profiling identifies CD8+ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer. Frontiers in Immunology. 13. 894919–894919. 13 indexed citations
9.
Yan, Kai, et al.. (2021). Dynamics of multipartite quantum coherence in asymmetric spin-orbit coupled system. Acta Physica Sinica. 70(1). 10301–10301.
10.
Wang, Jiancheng, Gang Yin, Bian Hu, et al.. (2021). LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma. Molecular Medicine. 27(1). 41–41. 31 indexed citations
11.
Dong, Wei, Kai Yan, Hua Yu, et al.. (2021). Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy. Frontiers in Oncology. 10. 605057–605057. 3 indexed citations
12.
Wang, Longrong, Kai Yan, Xigan He, et al.. (2020). LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. Journal of Cancer. 12(1). 217–223. 36 indexed citations
13.
Yan, Kai, Yi He, Qingzhi Liu, et al.. (2020). Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming. Cell Death and Disease. 11(9). 800–800. 37 indexed citations
14.
Luo, Mao, Rong Li, Xin Deng, et al.. (2015). Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes. Acta Diabetologica. 52(5). 943–949. 34 indexed citations
15.
Li, Rong, Mao Luo, Meiping Ren, et al.. (2014). Vitronectin Regulation of Vascular Endothelial Growth Factor-Mediated Angiogenesis. Journal of Vascular Research. 51(2). 110–117. 20 indexed citations
16.
Byrnes, Tim, Shinsuke Koyama, Kai Yan, & Y. Yamamoto. (2013). Neural networks using two-component Bose-Einstein condensates. Scientific Reports. 3(1). 2531–2531. 22 indexed citations
17.
Moulder, Stacy, Kai Yan, Fei Huang, et al.. (2010). Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy. Molecular Cancer Therapeutics. 9(5). 1120–1127. 27 indexed citations
18.
Shinde, Shivani, Michele R. Forman, Henry M. Kuerer, et al.. (2010). Higher parity and shorter breastfeeding duration. Cancer. 116(21). 4933–4943. 84 indexed citations
19.
André, Fabrice, Bastien Job, Philippe Dessen, et al.. (2009). Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array. Clinical Cancer Research. 15(2). 441–451. 248 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026